UFP Technologies shares surge 11.41% after-hours after Q3 revenue and EPS beat estimates on strong medical demand.

UFP Technologies surged 11.41% in after-hours trading following the release of its Q3 2025 earnings report, which showed revenue of $154.6 million—6.5% above year-ago levels and 3.3% above estimates—with adjusted earnings of $2.39 per share, a 10% beat. The company highlighted robust 7.3% growth in its MedTech segment, driven by double-digit increases in interventional and surgical products, and outlined a $10 million+ revenue ramp from two new robotic surgery programs in 2026. CEO Jeff Bailly emphasized progress in resolving labor challenges at its AJR facility and expanding a key contract with its largest customer, including multi-million-dollar investments to boost capacity. These results and forward-looking guidance aligned with the stock’s sharp post-earnings move, reflecting renewed investor confidence in the company’s long-term growth trajectory in the medical devices sector.